These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 2864398

  • 1. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW, Stanford EJ, Wyrick SW, Mailman RB.
    J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
    [Abstract] [Full Text] [Related]

  • 2. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 3. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D, Trovero F, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 1992 Feb 11; 46(3):687-700. PubMed ID: 1532052
    [Abstract] [Full Text] [Related]

  • 4. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 11; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 5. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R, López MG, del Valle M, Naranjo JR, Mellström B, García AG.
    Mol Pharmacol; 1995 Jan 11; 47(1):40-50. PubMed ID: 7838132
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
    Dubois A, Savasta M, Curet O, Scatton B.
    Neuroscience; 1986 Sep 11; 19(1):125-37. PubMed ID: 2946980
    [Abstract] [Full Text] [Related]

  • 7. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups.
    Dewar KM, Reader TA.
    J Neurochem; 1989 Feb 11; 52(2):472-82. PubMed ID: 2463335
    [Abstract] [Full Text] [Related]

  • 8. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
    Kokay IC, Mercer AR.
    Brain Res; 1996 Jan 08; 706(1):47-56. PubMed ID: 8720491
    [Abstract] [Full Text] [Related]

  • 9. Stereospecific binding of a new benzazepine, [3H]SCH23390, in cortex and neostriatum.
    Brière R, Diop L, Gottberg E, Grondin L, Reader TA.
    Can J Physiol Pharmacol; 1987 Jul 08; 65(7):1507-11. PubMed ID: 2889517
    [Abstract] [Full Text] [Related]

  • 10. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution.
    Reader TA, Brière R, Gottberg E, Diop L, Grondin L.
    J Neurochem; 1988 Feb 08; 50(2):451-63. PubMed ID: 2961849
    [Abstract] [Full Text] [Related]

  • 11. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M, Dubois A, Scatton B.
    Brain Res; 1986 Jun 11; 375(2):291-301. PubMed ID: 2942221
    [Abstract] [Full Text] [Related]

  • 12. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
    Flaim KE, Gessner GW, Crooke ST, Sarau HM, Weinstock J.
    Life Sci; 1985 Apr 15; 36(15):1427-36. PubMed ID: 2858801
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 15; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 17. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.
    Gottberg E, Diop L, Montreuil B, Reader TA.
    Neurochem Res; 1989 May 15; 14(5):419-26. PubMed ID: 2526301
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity.
    Reader TA, Grondin L, Montreuil B, Dewar KM.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec 15; 340(6):617-25. PubMed ID: 2575710
    [Abstract] [Full Text] [Related]

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 15; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
    Charifson PS, Wyrick SD, Hoffman AJ, Simmons RM, Bowen JP, McDougald DL, Mailman RB.
    J Med Chem; 1988 Oct 15; 31(10):1941-6. PubMed ID: 3050089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.